Yongbing Wu

1.0k total citations
35 papers, 710 citations indexed

About

Yongbing Wu is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yongbing Wu has authored 35 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yongbing Wu's work include RNA modifications and cancer (7 papers), Circular RNAs in diseases (5 papers) and Streptococcal Infections and Treatments (4 papers). Yongbing Wu is often cited by papers focused on RNA modifications and cancer (7 papers), Circular RNAs in diseases (5 papers) and Streptococcal Infections and Treatments (4 papers). Yongbing Wu collaborates with scholars based in China and United States. Yongbing Wu's co-authors include Jianjun Xu, Xiang Long, Shu‐Qiang Zhu, Bai‐Quan Qiu, Feng Lü, Xu Pei, Kun Lin, Shiwei Chen, Dian Xiong and Yunfei Liao and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Microbiology and Life Sciences.

In The Last Decade

Yongbing Wu

29 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongbing Wu China 14 530 343 110 99 84 35 710
Kiyoko Umene Japan 18 397 0.7× 267 0.8× 109 1.0× 75 0.8× 89 1.1× 32 841
Le Tao China 18 502 0.9× 349 1.0× 87 0.8× 60 0.6× 78 0.9× 31 828
Jiaxuan Chen China 12 260 0.5× 134 0.4× 143 1.3× 110 1.1× 50 0.6× 26 564
Qiying Chen China 14 448 0.8× 274 0.8× 51 0.5× 102 1.0× 98 1.2× 29 689
Tian Lan China 13 435 0.8× 404 1.2× 66 0.6× 51 0.5× 73 0.9× 21 728
Yimeng Song China 14 436 0.8× 283 0.8× 85 0.8× 57 0.6× 284 3.4× 42 683
Hongze Chen China 14 319 0.6× 214 0.6× 209 1.9× 83 0.8× 45 0.5× 21 594
Bijun Qiu China 12 445 0.8× 197 0.6× 185 1.7× 54 0.5× 61 0.7× 29 691
Hiroyuki Nojima Japan 13 362 0.7× 195 0.6× 138 1.3× 104 1.1× 74 0.9× 41 647

Countries citing papers authored by Yongbing Wu

Since Specialization
Citations

This map shows the geographic impact of Yongbing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongbing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongbing Wu more than expected).

Fields of papers citing papers by Yongbing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongbing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongbing Wu. The network helps show where Yongbing Wu may publish in the future.

Co-authorship network of co-authors of Yongbing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongbing Wu. A scholar is included among the top collaborators of Yongbing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongbing Wu. Yongbing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lingxian, et al.. (2025). Ufmylation Suppresses Unfolded Protein Response to Prevent Peripartum Cardiomyopathy. JACC Basic to Translational Science. 10(10). 101293–101293.
2.
Hu, Quan, et al.. (2025). A seizure case induced by topical application of tranexamic acid in a local incision. Korean journal of anesthesiology. 78(3). 292–294.
4.
Chen, Shiwei, Dingguo Wang, Dian Xiong, et al.. (2025). Targeting SHP2 to reverse immune evasion and resistance to anti-PD-1 therapy in non-small cell lung cancer. Cell Communication and Signaling. 23(1). 478–478. 1 indexed citations
5.
Guo, Junfei, et al.. (2024). Evaluation of microbiological epidemiology and clinical characteristics of maternal bloodstream infection: a 10 years retrospective study. Frontiers in Microbiology. 14. 1332611–1332611. 2 indexed citations
6.
Liao, Yunfei, Ben Ke, Xiaoyan Long, Jianjun Xu, & Yongbing Wu. (2023). Abnormalities in the SIRT1-SIRT3 axis promote myocardial ischemia-reperfusion injury through ferroptosis caused by silencing the PINK1/Parkin signaling pathway. BMC Cardiovascular Disorders. 23(1). 582–582. 23 indexed citations
7.
Guo, Junfei, et al.. (2023). Change of serum lipoproteins and its potential use in stratifying patients with sepsis among neonates. European journal of medical research. 28(1). 106–106.
8.
Lü, Feng, et al.. (2022). The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan‐Cancer Analysis. Oxidative Medicine and Cellular Longevity. 2022(1). 3355365–3355365.
9.
Gao, Jian, Xiang Long, Pengfei Zhang, et al.. (2022). The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis. Molecular Cancer. 21(1). 110–110. 88 indexed citations
10.
Xu, Jianjun, et al.. (2022). Minimally Invasive Myxoma Resection: A Single-Center 5 Years’ Experience. The Heart Surgery Forum. 25(3). E353–E357. 3 indexed citations
11.
Liao, Yunfei, Ben Ke, Xiaoyan Long, Jianjun Xu, & Yongbing Wu. (2022). Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease. BioMed Research International. 2022(1). 2114699–2114699. 5 indexed citations
12.
Lü, Feng, Shu‐Qiang Zhu, Xiang Long, et al.. (2021). Clinical study of minimally invasive aortic valve replacement through a right parasternal second intercostal transverse incision: The first Chinese experience. Asian Journal of Surgery. 44(8). 1063–1068. 8 indexed citations
13.
Ye, Xudong, Bai‐Quan Qiu, Dian Xiong, et al.. (2020). High level of H3K4 tri-methylation modification predicts poor prognosis in esophageal cancer. Journal of Cancer. 11(11). 3256–3263. 4 indexed citations
14.
Wang, Jiwei, Yao Cai, Yongbing Wu, & Bin Lai. (2020). Asymptomatic long‐segmental type A aortic dissection diagnosed by transthoracic echocardiography: A case report and literature review. Journal of Clinical Ultrasound. 48(9). 574–578. 1 indexed citations
16.
Guo, Junfei, Yongbing Wu, Weiming Lai, Weiming Lü, & Xiaoping Mu. (2019). The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis. BMC Infectious Diseases. 19(1). 716–716. 13 indexed citations
17.
Xiong, Dian, Shu‐Qiang Zhu, Yongbing Wu, et al.. (2018). Ring finger protein 38 promote non-small cell lung cancer progression by endowing cell EMT phenotype. Journal of Cancer. 9(5). 841–850. 18 indexed citations
18.
Liao, Yunfei, et al.. (2017). Minimally access via left anterior mini-thoracotomy for repair of adult subarterial ventricular septal defects. Journal of Cardiothoracic Surgery. 12(1). 48–48. 5 indexed citations
19.
Li, Juxiang, Jianping Hu, Kui Hong, et al.. (2017). Double ventricular response in dual AV nodal pathways mimicking interpolated premature beat. Herz. 43(2). 156–160. 3 indexed citations
20.
Li, Jiehui, et al.. (2012). Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients. Journal of Cardiothoracic Surgery. 7(1). 97–97. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026